We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Lexicon Says IBS Drug Met Mid-Stage Study Goal
Lexicon Says IBS Drug Met Mid-Stage Study Goal
November 13, 2009
Lexicon Pharmaceuticals Inc. said an irritable bowel syndrome drug candidate met its goals
in a mid-stage clinical trial. Yahoo! Finance
